snoRNA来源RNA在健康造血与急性髓系白血病中的功能表征
该研究刻画了造血干祖细胞、健康白细胞及159例初诊强化治疗AML患者的sdRNA与snoRNA表达谱,发现sdRNA表达模式可区分细胞类型;AML中高sd3'-RNA/snoRNA宿主基因比值与不良预后相关,尤其在NPM1突变低危患者中可识别预后较差亚组,并涉及致癌、炎症与免疫信号改变。
要点
- sdRNA表达模式可区分HSPCs、健康白细胞与AML原始细胞。
- AML中高sd3'-RNA/snoRNA宿主基因比值与不良预后相关。
- NPM1突变低危患者中高sd3'-RNA比值可识别预后较差亚组。
核心结论
- sdRNA是健康造血与AML中独立的调控效应分子。
- 高sd3'-RNA/snoRNA宿主基因比值与AML患者不良预后相关。
研究设计与样本
- 研究刻画了造血干祖细胞、健康白细胞及159例初诊强化治疗AML患者的sdRNA与snoRNA水平。
主要发现
- HSPCs、健康白细胞与AML原始细胞可按sdRNA表达模式以细胞类型特异性方式区分。
- AML中高sd3'-RNA/snoRNA宿主基因比值与患者不良结局相关。
- NPM1突变且风险分层良好、初始治疗反应好的患者中,高sd3'-RNA比值识别出预后较差亚组。
- 高sd3'-RNA比值与致癌、炎症及免疫应答信号改变相关。
- 强制表达sd3'-SNORD78、sd3'-SNORD76或sd5'-SNORD93可增强AML克隆形成潜能,并在AML与健康HSPCs中驱动sdRNA特异性基因表达特征。
临床怎么用
- 在高sd3'-RNA比值的AML患者中,尤其NPM1突变低危且初始反应良好者,需关注 inferior outcome 风险。
- sdRNA表达模式或可作为区分HSPCs、健康白细胞与AML原始细胞的分子特征。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
SnoRNAs are highly expressed in AML and have implications in leukemogenesis and leukemic maintenance. SnoRNAs can be further processed into snoRNA-derived RNAs (sdRNAs). The role of sdRNAs in AML and healthy hematopoiesis remains largely elusive. We characterized sdRNA and snoRNA levels in hematopoietic stem and progenitor cells (HSPCs), healthy WBCs, and 159 intensively treated AML patient samples at initial diagnosis. HSPCs, healthy WBCs, and AML blasts could be differentiated by their sdRNA expression pattern in a cell-type-specific manner. In AML, high sd3'-RNA/snoRNA-host gene ratios were associated with an inverse patient outcome. Particularly, in NPM1-mutated patients with favorable risk stratification and good initial therapy response, high sd3'-RNA ratios identified a subgroup with inferior outcome. High sd3'-RNA ratios were associated with altered oncogenic, inflammatory, and immune response signaling. Forced expression of single sdRNAs, such as sd3'-SNORD78, sd3'-SNORD76, and sd5'-SNORD93, enhanced clonogenic potential in AML and drove sdRNA-specific gene expression signatures in both AML and healthy HSPCs. Exemplarily, we propose and characterize NUDT21, an important regulator of alternative polyadenylation and oncogenic gene expression, as a downstream target of sd3'-SNORD78 in AML. Our data introduce sdRNAs as standalone regulatory effector molecules in healthy hematopoiesis and AML.
引用
- Zinz R, Rohde C, Pauli C, et al. Functional characterization of snoRNA-derived RNA (sdRNA) expression in healthy hematopoiesis and acute myeloid leukemia. Leukemia. 2026. PMID: 42697931. doi:10.1038/s41375-026-03120-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。